Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Processa Pharmaceuticals Inc (PCSA)

Processa Pharmaceuticals Inc (PCSA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 122,343
  • Shares Outstanding, K 15,605
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,410 K
  • 60-Month Beta 0.31
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.52
Trade PCSA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +61.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.18 +52.70%
on 08/19/21
7.91 unch
on 09/17/21
+2.31 (+41.25%)
since 08/17/21
3-Month
5.12 +54.52%
on 08/16/21
8.94 -11.52%
on 06/25/21
+1.26 (+18.95%)
since 06/17/21
52-Week
3.40 +132.65%
on 10/02/20
14.24 -44.45%
on 03/19/21
-0.09 (-1.13%)
since 09/17/20

Most Recent Stories

More News
InvestorNewsBreaks Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Investor Conferences

(MENAFN - Investor Brand Network) Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with...

PCSA : 7.91 (+0.89%)
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), ("Processa" or the "Company"), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients...

PCSA : 7.91 (+0.89%)
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), ("Processa" or the "Company"), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients...

PCSA : 7.91 (+0.89%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 1.770 (unch)
ACER : 2.46 (-0.40%)
ADXN : 9.24 (-4.54%)
AGRX : 1.0800 (+4.85%)
ATGN : 1.9600 (+4.26%)
ABIO : 3.10 (+1.64%)
AUUD : 2.69 (-14.33%)
BASA : 0.3299 (-0.03%)
BMRA : 4.65 (+10.71%)
BKTI : 2.99 (+2.40%)
BSFC : 6.4000 (+2.56%)
DTST : 5.27 (+0.76%)
DCTH : 9.12 (+0.44%)
DMIFF : 0.2200 (-4.35%)
DLPN : 12.36 (-0.56%)
FLUX : 6.38 (-4.63%)
GBNH : 8.85 (+0.57%)
HAVLF : 0.2275 (-0.57%)
ISDR : 27.17 (+3.01%)
INLB : 1.5800 (-6.51%)
KNWN : 2.4300 (+2.10%)
LXXGF : 0.3900 (-0.76%)
MKTY : 8.83 (+1.38%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (-2.78%)
NEPH : 9.03 (+0.67%)
NMTC : 4.05 (-7.74%)
NLSP : 2.63 (-4.01%)
OBLG : 2.50 (-0.79%)
PBLA : 2.16 (-6.09%)
POSAF : 1.0200 (+2.33%)
PCSA : 7.91 (+0.89%)
PTIX : 1.9200 (-1.03%)
QOEG : 0.1000 (+58.73%)
QIPT : 5.78 (-3.02%)
SNGX : 1.0800 (+1.89%)
STRR : 2.67 (-0.37%)
TGCB : 0.7500 (unch)
VERB : 1.9100 (+1.60%)
WTEQ.CN : 0.120 (unch)
WINT : 1.8900 (+3.85%)
AYRO : 3.64 (unch)
BCTX : 7.86 (+3.97%)
BTX : 11.95 (-3.40%)
HWAL : 1.7500 (-2.78%)
NMRD : 6.88 (+3.46%)
THBRF : 3.5000 (-3.05%)
TRIQ : 0.9999 (+11.10%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 1.770 (unch)
ACER : 2.46 (-0.40%)
ADXN : 9.24 (-4.54%)
AGRX : 1.0800 (+4.85%)
ATGN : 1.9600 (+4.26%)
ABIO : 3.10 (+1.64%)
AUUD : 2.69 (-14.33%)
BASA : 0.3299 (-0.03%)
BKTI : 2.99 (+2.40%)
BSFC : 6.4000 (+2.56%)
DTST : 5.27 (+0.76%)
DCTH : 9.12 (+0.44%)
DMIFF : 0.2200 (-4.35%)
DLPN : 12.36 (-0.56%)
FLUX : 6.38 (-4.63%)
GBNH : 8.85 (+0.57%)
HAVLF : 0.2275 (-0.57%)
ISDR : 27.17 (+3.01%)
INLB : 1.5800 (-6.51%)
KNWN : 2.4300 (+2.10%)
LXXGF : 0.3900 (-0.76%)
MKTY : 8.83 (+1.38%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0500 (-2.78%)
NEPH : 9.03 (+0.67%)
NMTC : 4.05 (-7.74%)
NLSP : 2.63 (-4.01%)
OBLG : 2.50 (-0.79%)
PBLA : 2.16 (-6.09%)
POSAF : 1.0200 (+2.33%)
PCSA : 7.91 (+0.89%)
PTIX : 1.9200 (-1.03%)
QOEG : 0.1000 (+58.73%)
QIPT : 5.78 (-3.02%)
SNGX : 1.0800 (+1.89%)
STRR : 2.67 (-0.37%)
TGCB : 0.7500 (unch)
VERB : 1.9100 (+1.60%)
WTEQ.CN : 0.120 (unch)
WINT : 1.8900 (+3.85%)
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR THE DEVELOPMENT OF RX-3117

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that it has entered into a licensing agreement with Ocuphire Pharma, Inc. (NASDAQ: OCUP) to license in RX-3117. RX-3117 is an oral, anticancer...

PCSA : 7.91 (+0.89%)
OCUP : 5.19 (-0.38%)
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), ("Processa" or the "Company"), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients...

PCSA : 7.91 (+0.89%)
Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica

~Processa's trial is currently enrolling patients with ulcerated Necrobiosis Lipoidica. Detailed information on the trial can be located on clinicaltrials.gov NCT#: 04800562.~

PCSA : 7.91 (+0.89%)
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), ("Processa" or the "Company"), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients...

PCSA : 7.91 (+0.89%)
Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate Update

Clinical drug pipeline is funded and targeting major milestones in Q2 and 2H 2021

PCSA : 7.91 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.

See More

Key Turning Points

3rd Resistance Point 8.39
2nd Resistance Point 8.15
1st Resistance Point 8.03
Last Price 7.91
1st Support Level 7.67
2nd Support Level 7.43
3rd Support Level 7.31

See More

52-Week High 14.24
Fibonacci 61.8% 10.10
Fibonacci 50% 8.82
Last Price 7.91
Fibonacci 38.2% 7.54
52-Week Low 3.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar